Free Trial

Riot Platforms (RIOT) Competitors

$10.66
-0.25 (-2.29%)
(As of 06/18/2024 ET)

RIOT vs. VIVO, OSTK, OXFD, AWH, SOFI, COOP, CLSK, WD, QFIN, and UPST

Should you be buying Riot Platforms stock or one of its competitors? The main competitors of Riot Platforms include Meridian Bioscience (VIVO), Overstock.com (OSTK), Oxford Immunotec Global (OXFD), Aspira Women's Health (AWH), SoFi Technologies (SOFI), Mr. Cooper Group (COOP), CleanSpark (CLSK), Walker & Dunlop (WD), Qifu Technology (QFIN), and Upstart (UPST).

Riot Platforms vs.

Meridian Bioscience (NASDAQ:VIVO) and Riot Platforms (NASDAQ:RIOT) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation.

Riot Platforms has a net margin of 76.02% compared to Riot Platforms' net margin of 12.70%. Riot Platforms' return on equity of 16.74% beat Meridian Bioscience's return on equity.

Company Net Margins Return on Equity Return on Assets
Meridian Bioscience12.70% 16.74% 13.09%
Riot Platforms 76.02%12.56%11.66%

In the previous week, Riot Platforms had 12 more articles in the media than Meridian Bioscience. MarketBeat recorded 12 mentions for Riot Platforms and 0 mentions for Meridian Bioscience. Meridian Bioscience's average media sentiment score of 0.49 beat Riot Platforms' score of 0.00 indicating that Riot Platforms is being referred to more favorably in the news media.

Company Overall Sentiment
Meridian Bioscience Neutral
Riot Platforms Neutral

Riot Platforms has a consensus target price of $18.10, indicating a potential upside of 69.79%. Given Meridian Bioscience's higher possible upside, analysts clearly believe Riot Platforms is more favorable than Meridian Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Meridian Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Riot Platforms
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.11

Meridian Bioscience has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, Riot Platforms has a beta of 4.06, suggesting that its share price is 306% more volatile than the S&P 500.

Riot Platforms received 186 more outperform votes than Meridian Bioscience when rated by MarketBeat users. Likewise, 67.56% of users gave Riot Platforms an outperform vote while only 50.16% of users gave Meridian Bioscience an outperform vote.

CompanyUnderperformOutperform
Meridian BioscienceOutperform Votes
316
50.16%
Underperform Votes
314
49.84%
Riot PlatformsOutperform Votes
502
67.56%
Underperform Votes
241
32.44%

Meridian Bioscience has higher revenue and earnings than Riot Platforms. Riot Platforms is trading at a lower price-to-earnings ratio than Meridian Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Meridian Bioscience$333.02M4.49$42.46M$0.9735.02
Riot Platforms$280.70M10.97-$49.47M$0.8712.25

89.7% of Meridian Bioscience shares are held by institutional investors. Comparatively, 40.3% of Riot Platforms shares are held by institutional investors. 2.3% of Meridian Bioscience shares are held by company insiders. Comparatively, 4.4% of Riot Platforms shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Riot Platforms beats Meridian Bioscience on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RIOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RIOT vs. The Competition

MetricRiot PlatformsNondepository credit institutions IndustryBusiness SectorNASDAQ Exchange
Market Cap$3.08B$6.35B$6.41B$8.47B
Dividend YieldN/A5.43%2.94%4.09%
P/E Ratio12.257.1834.8016.66
Price / Sales10.977.631,132.3065.46
Price / Cash10.7226.0524.5930.41
Price / Book1.172.034.254.26
Net Income-$49.47M$441.57M$120.14M$215.55M
7 Day Performance0.19%-1.55%-2.36%-2.17%
1 Month Performance5.96%9.32%-2.11%-3.84%
1 Year Performance2.50%64.15%7.30%0.39%

Riot Platforms Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VIVO
Meridian Bioscience
0 of 5 stars
$33.97
flat
N/AN/A$1.50B$333.02M35.02702Analyst Forecast
OSTK
Overstock.com
0.5538 of 5 stars
N/A$27.00
+∞
N/A$760.30M$1.93B-4.671,050Analyst Forecast
Gap Up
OXFD
Oxford Immunotec Global
0 of 5 stars
$21.99
flat
N/AN/A$570.90M$73.71M-32.82273Analyst Forecast
AWH
Aspira Women's Health
1.6996 of 5 stars
$1.86
-6.1%
$4.45
+139.2%
-45.7%$23.16M$9.15M-1.2864Positive News
High Trading Volume
SOFI
SoFi Technologies
2.6239 of 5 stars
$7.07
+1.0%
$9.08
+28.5%
-25.3%$7.47B$2.12B-22.814,400Gap Up
COOP
Mr. Cooper Group
4.6393 of 5 stars
$83.35
+3.0%
$85.13
+2.1%
+69.7%$5.24B$2.63B8.736,800Short Interest ↓
CLSK
CleanSpark
0.6108 of 5 stars
$17.25
+8.2%
$19.97
+15.7%
+402.1%$3.63B$284.99M0.00130Analyst Forecast
Short Interest ↓
Gap Down
WD
Walker & Dunlop
1.2557 of 5 stars
$97.56
+5.8%
$100.00
+2.5%
+20.4%$3.29B$1.05B35.611,326News Coverage
QFIN
Qifu Technology
4.9378 of 5 stars
$20.17
+0.2%
$24.73
+22.6%
+22.6%$3.26B$2.29B5.233,121Positive News
UPST
Upstart
2.257 of 5 stars
$24.98
+2.7%
$21.65
-13.3%
-40.3%$2.20B$513.56M-12.131,388Gap Up

Related Companies and Tools

This page (NASDAQ:RIOT) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners